Fermented Millet Porridge, Gut Microbiota and Inflammation Status in Women

NCT ID: NCT05299970

Last Updated: 2023-10-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

80 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-03-21

Study Completion Date

2024-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Maternal undernutrition concerns 10-19% of women of reproductive age globally, the vast majority of which live in sub Saharan Africa and south Asia. Recommendations for nutritional interventions to tackle the problem range from per-pregnancy supplementation to upstream interventions targeting women of reproductive age before conception. To render the latter interventions cost-effective and sustainable, experts recommend to focus on food processing that leads to an enhanced nutrient content. One such method, which has been known and practiced for centuries in diverse societies, is fermentation. Traditionally fermented foods are diverse, widespread and highly appreciated in Burkina Faso. The present study aims to investigate the effect of fermented millet porridge on gut microbiota diversity, stool short chain fatty acid concentration and inflammation markers level in women of reproductive age living in rural Burkina Faso.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Inflammation Microbiome, Human

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SCREENING

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

fermented porridge

this study arm participant will consume fermented millet porridge, daily

Group Type EXPERIMENTAL

Fermented porridge

Intervention Type OTHER

A millet porridge (fermented or not, depending on group allocation) serving will be provided to participants daily, for consumption. consumption will be directly observed.

Non-fermented porridge

this study arm participants will consume non-fermented millet porridge, daily

Group Type ACTIVE_COMPARATOR

Fermented porridge

Intervention Type OTHER

A millet porridge (fermented or not, depending on group allocation) serving will be provided to participants daily, for consumption. consumption will be directly observed.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Fermented porridge

A millet porridge (fermented or not, depending on group allocation) serving will be provided to participants daily, for consumption. consumption will be directly observed.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Participant are

* 18 to 49 years old
* Resident in the study area and do not plan to move within 5 months following the start of the study
* Are not on antibiotic treatment on inclusion and have not been in the previous 3 weeks.
* Do not suffer from any pathology that could interfere with their diet.
* Have no known allergy to pearl millet or its derivatives
* Agree to sign a consent to participate in the study-

Exclusion Criteria

* Women under 18 or over 49
* Women not consuming pearl millet porridge due to allergy or food preference
* Women planning to move from the study area within 5 months of the start of the study
* Women with serious illnesses that may interfere with their diet
* Women on antibiotic treatment or at the time of inclusion or having been in the previous 3 weeks.
* In addition, women who will benefit from antibiotic therapy during the study will be excluded from the analysis
Minimum Eligible Age

18 Years

Maximum Eligible Age

49 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Ghent

OTHER

Sponsor Role collaborator

Bill and Melinda Gates Foundation

OTHER

Sponsor Role collaborator

Institut de Recherche en Sciences de la Sante, Burkina Faso

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Laeticia Celine Toe

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Laeticia C TOE

Role: PRINCIPAL_INVESTIGATOR

IRSS-DRO

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

IRSS-DRO

Bobo-Dioulasso, Houet, Région Des hauts-Bassins, Burkina Faso

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Burkina Faso

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Laeticia C TOE, MD

Role: CONTACT

0022671007272

Lionel O Ouedraogo

Role: CONTACT

0022670530583

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Lionel WB Ouedraogo, MD

Role: primary

+22670530583

Laeticia C TOE, MD

Role: backup

+22671007272

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NUT_IRSS_0001

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

The Maternal EED Study
NCT05862363 RECRUITING NA
Screening for Acute Malnutrition
NCT05284773 WITHDRAWN NA